Navigation Links
PhotoMedex Increases Access to Care for Children in Recognition of World Psoriasis Day, Oct. 29

MONTGOMERYVILLE, Pa., Oct. 24, 2011 /PRNewswire/ -- PhotoMedex, Inc. (NASDAQ: PHMD), an innovator of medical devices, including the XTRAC® excimer laser (, is offering a special co-pay reimbursement program to increase access to XTRAC psoriasis treatments for children, an underserved population of psoriasis patients.

The offer is being presented in recognition of World Psoriasis Day on October 29. Conceived by patients for patients, World Psoriasis Day is a global event focusing on increasing awareness about the burdens of living with psoriasis, a severe chronic inflammatory disease that affects all ages, genders, races and ethnicities.  Globally, more than 125 million people suffer from psoriasis/psoriatic arthritis, many of whom are children. In the United States alone, more than 20,000 children a year are diagnosed.

The painless XTRAC excimer laser provides targeted phototherapy treatment for psoriasis; offering a safe, effective treatment with longer lasting results. Other treatment options for psoriasis, such as topical steroids, full-body UVB, systemic medications and biologics can have dangerous side effects.  The XTRAC is the safest choice for children, as it accurately targets only the affected areas with safe, phototherapy light. Because there is currently no cure for psoriasis, patients who develop the disease at a young age need to utilize a safe, effective treatment that will not produce negative, long-term side effects.  The XTRAC excimer laser is the only clinically proven, FDA-cleared dermatology excimer laser with independent safety and quality certifications.

"For children, the treatment options are often more limited than for adults, and those that are available often have many dangers associated with them or become ineffective over time," said Dr. Barry Auster, dermatologist at Oakland Aesthetic Dermatology in Farmington Hills, Mich. "The XTRAC excimer laser treatment is a great option for children because it provides safe, effective and lasting results that eliminate the need for messy creams or steroids. This co-pay reimbursement offer can help children, who may have otherwise not considered the treatment because of costs, finally experience relief."

Inconsistent care and access to care are two major issues for all psoriasis sufferers but are even more of a concern for children.  According to a recent study, children with psoriasis are most likely to receive inconsistent care, and the course of treatment prescribed may depend on whether they see a pediatrician, dermatologist or internist. In 3.8 million visits, about 63 percent of kids saw a dermatologist, 17 percent saw a pediatrician, and 14 percent went to an internist. Researchers found that pediatricians, dermatologists and internists often take different approaches to how they treat children with psoriasis, including the types and strengths of medication they use. It is important that psoriasis sufferers see a qualified dermatologist who offers the latest, safest and most effective treatment options, such as the XTRAC laser.

Broad coverage of the XTRAC treatments for psoriasis by Medicare and all major insurance companies now provides greater access to care for psoriasis sufferers who have spent their lives suffering from dry, red and itchy skin, among other symptoms associated with the disease.

For more information about the XTRAC excimer laser, visit The website features a telecare center where patients can speak directly with highly experienced clinical specialists about the XTRAC laser therapy. The specialists also will assist those interested in making appointments with physicians experienced in providing XTRAC laser treatments.

Connect with XTRAC on Twitter - and on

Facebook -

About PhotoMedex

PhotoMedex is a leader in the development, manufacturing, and global marketing of dermatology products and techniques focused on advancing cost-effective technologies that provide patients with better outcomes and a higher quality of life. The company is uniquely positioned to research and commercialize therapies that innovatively combine both medical devices and science-based aesthetic products. Medical devices include the XTRAC®  Excimer Laser for the treatment of skin diseases like psoriasis and vitiligo; and the Omnilux™ non-laser light-emitting diodes (LED) for the treatment of clinical and aesthetic dermatological conditions, including acne, photodamage, skin rejuvenation, and wound healing. Adding to these therapies, the company markets a broad range of specialty skin-care products based upon its clinically proven DNA + Copper Peptide technologies for skin heath and Copper Peptide Complexes for hair and wound care, including its NEOVA®, DNA Damage Control™, Tricomin® and Graftcyte® brands. PhotoMedex sells directly to dermatologists; plastic and cosmetic surgeons, spas; salons; and, through strategic partners, in the consumer market. In addition, the company manufactures and distributes surgical lasers and disposables to hospitals and surgery centers for procedures in multiple surgical specialties.  For more information please visit


SOURCE PhotoMedex, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PhotoMedex Covers XTRAC Laser Treatment Co-Pay for Children with Psoriasis
2. PhotoMedexs Itching to Win Contest Offers Free Phototherapy Treatments With the XTRAC Laser to Deserving Psoriasis Patients Nationwide
3. PhotoMedex Launches New Patient-Focused XTRAC Laser Website
4. Practices Using SuccessEHS See Immediate Increases in Productivity After Go-Live
5. Research Suggests FORTEO® Significantly Increases Bone Strength
6. Varian Medical Systems Announces $250 Million Accelerated Stock Repurchase; Increases Its Revolving Credit Facility
7. Prime Therapeutics Drug Trend Insights Reports One of the Lowest Drug Spending Increases in the Industry
8. Fero Industries Increases Sucanon® Promotion in Mexico with Physician Distributed Sample Packages
9. HeartSine® Increases AED System Warranty to Longest in the Industry
10. Improved Endoscopy Method Increases Detection of Esophageal Pre-Cancer by Over 40 Percent
11. InspireMD Increases Geographic Penetration; MGuard Stent is Now Available in India
Post Your Comments:
(Date:11/30/2015)... 2015 Cumberland Pharmaceuticals (CPIX), today announced that A.J. ... on December 3, 2015. TIME: 3:15p.m. ET LINK: ... LINK: --> DATE: Thursday, ... --> --> This ... invited to ask the company questions in real-time - both ...
(Date:11/30/2015)... 2015 Varian Medical Systems (NYSE: VAR ) has ... with Apollo Hospitals Group, the largest hospital chain in ... radiation technologists in the country. The MoU was signed by Dr. ... Ashok Kakkar , Varian,s India managing ... India , Varian intends to deploy its Access to Care ...
(Date:11/30/2015)... LONDON and BOSTON , ... to research and develop potential new medicines directed at ... multiple therapeutic areas. --> PFE ) to ... to 10 G protein-coupled receptor (GPCR) targets across multiple ... clinical-stage GPCR structure-guided drug discovery and development company and ...
Breaking Medicine Technology:
(Date:11/30/2015)... , ... November 30, 2015 , ... Cycling, running, and ... take on extra meaning the morning of February 28, 2016. , That’s when ... Park and thousands will exercise to help children and families at Joe DiMaggio ...
(Date:11/30/2015)... ... November 30, 2015 , ... A ... of bacteria could be effective in fighting methicillin-resistant Staphylococcus aureus (MRSA), one of ... Their study showed that small molecule analogs that target the functions of SecA, ...
(Date:11/30/2015)... ... November 30, 2015 , ... Using a combination of two blood ... children and adults, according to a new study by researchers at the School of ... Children and Adults: Using Combinations of Blood Glucose Tests ,” published in Frontiers in ...
(Date:11/30/2015)... ... November 30, 2015 , ... International telepathology consultations can ... and KingMed Diagnostics researchers. Their review of more than 1,500 pathology ... pathologists resulted in significantly altered treatment plans for more than half of the ...
(Date:11/30/2015)... PHILADELPHIA (PRWEB) , ... November 30, 2015 , ... ... Philadelphia-based non-profit promoting breast and prostate cancer education and prevention—is joining forces with ... evening of philanthropy and Hollywood elegance on December 7, 2015 at the Union ...
Breaking Medicine News(10 mins):